Literature DB >> 12057131

Endometrial carcinoma.

W K Huh1, J M Straughn, F J Kelly, L C Kilgore.   

Abstract

Endometrial cancer is a common tumor of the female genital tract. The majority of women diagnosed with endometrial cancer present with early-stage disease. Although the optimal treatment for these patients requires hysterectomy, the use of lymphadenectomy is controversial. Growing scientific data support the use of lymphadenectomy in all patients diagnosed with endometrial cancer. When performed by an experienced surgeon, pelvic and para-aortic lymphadenectomy is a safe and potentially therapeutic procedure that provides prognostic information to the patient and physician. This information allows appropriate, cost-effective treatment strategies to be created for all women with endometrial cancer.

Entities:  

Mesh:

Year:  2001        PMID: 12057131     DOI: 10.1007/s11864-001-0055-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  40 in total

1.  Treatment for early endometrial cancer. Cost-effectiveness analysis.

Authors:  J Fanning
Journal:  J Reprod Med       Date:  1999-08       Impact factor: 0.142

2.  Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality.

Authors:  D M Larson; K Johnson; K A Olson
Journal:  Obstet Gynecol       Date:  1992-06       Impact factor: 7.661

3.  Intraoperative evaluation of prognostic factors in stage I endometrial cancer by frozen section: how reliable?

Authors:  C G Zorlu; E Kuscu; Y Ergun; T Aydogdu; O Cobanoglu; O Erdas
Journal:  Acta Obstet Gynecol Scand       Date:  1993-07       Impact factor: 3.636

4.  Comparison of clinical and surgical-staging in patients with endometrial carcinoma.

Authors:  T A Cowles; J F Magrina; B J Masterson; C V Capen
Journal:  Obstet Gynecol       Date:  1985-09       Impact factor: 7.661

5.  A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact.

Authors:  M N Barnes; P Y Roland; M Straughn; L C Kilgore; R D Alvarez; E E Partridge
Journal:  Gynecol Oncol       Date:  1999-09       Impact factor: 5.482

6.  Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study.

Authors:  W T Creasman; K DeGeest; P J DiSaia; R J Zaino
Journal:  Am J Obstet Gynecol       Date:  1999-07       Impact factor: 8.661

7.  Stage I corpus cancer: is teletherapy necessary?

Authors:  J W Orr; J L Holimon; P F Orr
Journal:  Am J Obstet Gynecol       Date:  1997-04       Impact factor: 8.661

8.  Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery.

Authors:  S S Chen
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

9.  Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy.

Authors:  Y B Kim; J M Niloff
Journal:  Obstet Gynecol       Date:  1993-08       Impact factor: 7.661

10.  Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.

Authors:  J Aalders; V Abeler; P Kolstad; M Onsrud
Journal:  Obstet Gynecol       Date:  1980-10       Impact factor: 7.661

View more
  1 in total

1.  Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group.

Authors:  Jung Yun Lee; Kidong Kim; Taek Sang Lee; Sokbom Kang; Seok Ju Seong; Jae Weon Kim; Byoung Gie Kim
Journal:  J Gynecol Oncol       Date:  2015-09-23       Impact factor: 4.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.